For chicken growers who grow 40 billion chickens per year for worldwide consumption, Salmogenics is very cost effective, reducing the cost of administration.
This means not only a healthier chicken, but a healthier source of protein for humans!
Global Green, Inc. plans to manufacture, market and sell the patented, exclusively licensed vaccine known as the “Salmogenics Vaccine.” Salmogenics™ was developed by Nutritional Health Institute Laboratories, LLC, a research affiliate and majority shareholder, to combat Salmonella bacteria in poultry and eggs. The vaccine is currently in the last stage of the USDA approval process. The vaccine is unique in that it is injected directly into the egg, before the chick is hatched, improving the immune system, health and welfare of the chicken, and providing a healthier source of protein for humans.
View Stock Information
- February 22, 2019 An Important Pilot Study for the Vaccine was Finished in 2018 TALLAHASSEE, Fla. – February 22, 2019- Global Green, Inc., a green bio-pharmaceutical Company provides the following …Read More »
- The Company filed Form 8-K in December 2015 http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=11086364Read More »